Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Isabelle Debergh

Awards & Distinctions

15 Results

2015

Microvascular effects of the low molecular weight heparins in a colorectal xenograft model: an intravital microscopy study

ISABELLE DEBERGHPiet PattynWim Ceelen

A1 Journal Article in JOURNAL OF SURGICAL RESEARCH

2014

Integrated study of the effects of antiangiogenic therapy on microvascular physiology in human cancer models

ISABELLE DEBERGHWim CeelenPiet Pattyn

Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ3 integrin

ISABELLE DEBERGHNancy Van DammeDieter De NaeyerPeter SmeetsPieter DemetterPhilippe RobertSabin CarmePiet PattynWim Ceelen

A1 Journal Article in ANNALS OF SURGICAL ONCOLOGY

2012

Innovation in cancer imaging

ISABELLE DEBERGHChristian VanhoveWim Ceelen

A1 Journal Article in EUROPEAN SURGICAL RESEARCH

2011

Antitumour efficacy of two paclitaxel formulations for hyperthermic intraperitoneal chemotherapy (HIPEC) in an in vivo rat model

Wim Bouquet-GeerardynSteven DeleyeSteven StaelensLieselotte De SmetNancy Van DammeISABELLE DEBERGHWim CeelenFilip De VosJean Paul RemonChris Vervaet

A1 Journal Article in PHARMACEUTICAL RESEARCH

First order correction for T*2-relaxation in determining contrast agent concentration from spoiled gradient echo pulse sequence signal intensity

Dieter De NaeyerISABELLE DEBERGHYves De DeeneWim CeelenPatrick SegersPascal Verdonck

A1 Journal Article in JOURNAL OF MAGNETIC RESONANCE IMAGING

2010

The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model

ISABELLE DEBERGHNancy Van DammePiet PattynMarc PeetersWim Ceelen

A1 Journal Article in BRITISH JOURNAL OF CANCER

2009

Low molecular weight heparin inhibits tumor associated angiogenesis in vivo

ISABELLE DEBERGHNancy Van DammePiet PattynMarc PeetersWim Ceelen

Low molecular weight heparin inhibits tumor associated angiogenesis in vivo

ISABELLE DEBERGHNancy Van DammePiet PattynMarc PeetersWim Ceelen

MOLECULAR IMAGING OF TUMOR ASSOCIATED ANGIOGENESIS USING P1227, A NOVEL MRI CONTRAST AGENT TARGETING AVB3 INTEGRIN

ISABELLE DEBERGHNancy Van DammePeter SmeetsP DemetterS CarmePiet PattynM PeetersWim Ceelen

2008

EFFECTS OF THE LOW MOLECULAR WEIGHT HEPARIN NADROPARIN ON TUMOR ASSOCIATED ANGIOGENESIS

ISABELLE DEBERGHMarc PeetersWim Ceelen

Effects of the low molecular weight heparin nadroparin on tumor associated angiogenesis

ISABELLE DEBERGHNancy Van DammePiet PattynMarc PeetersWim Ceelen

Effects of the low molecular weight heparin nadroparin on tumour associated angiogenesis

ISABELLE DEBERGHNancy Van DammeMarc PeetersPiet PattynWim Ceelen

Molecular imaging of tumor associated angiogenesis using P1227, a noval MRI contrast agent targeting Alfa V Beta 3 integrin

ISABELLE DEBERGHNancy Van DammePeter SmeetsPiet PattynMarc PeetersWim Ceelen

Molecular imaging of tumor associated angiogenesis uzing P1127, a novel MRI contrast agent targeting alfa V beta 3 integrin

ISABELLE DEBERGHNancy Van DammePeter SmeetsMarc PeetersPiet PattynWim Ceelen